You searched for "fundoscopy"
Best way to detect glaucoma progression: by reflecting on the past 25 years
1 June 2018
| Leon Au, Cecilia Fenerty
|
EYE - Glaucoma
Glaucoma – a condition of optic neuropathy leading to progressive visual field loss often associated with raised intraocular pressure. It is fair to say that our definition for this condition has remained unchanged over the last 25 years and the...
Long-term specular microscopy following Nd: YAG iridotomy in chronic POAG
1 April 2018
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
The aim of this study was to evaluate specular microscopy of chronic primary angle-closure glaucoma (CPACG) eyes at least one year after Nd:YAG iridotomy, and compare them with CPACG eyes without an iridotomy and age-matched, normal eyes. Nd:YAG laser causes...
HS-UK to be authorised distributor for the Vision Engineering 3D Deep Reality Viewer
23 January 2023
|
Contracts & Distributors
HS-UK is delighted to announce that it is now the authorised distributor for the Deep Reality Viewer (DRV) in the UK.
Report: UKEGS 2024
29 October 2024
|
UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...
Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting
3 October 2022
| Aiman Jamal, Shreya Haldar, Sarah Twallin, Asifa Shaikh
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...
The results of the last survey Dec20
The responses to the first question in this survey demonstrate the need for it and the significant variation in practice we see in even relatively simple management decisions. Patients are seen regularly with occludable drainage angles and listed for YAG...The results of the last survey Oct24
3 October 2024
| Amar Alwitry
|
EYE - Glaucoma
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. The sample...
Systemic sarcoidosis presenting with acute myopia and angle closure
1 June 2016
| Naser Ali, Sher Aslam
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Strabismus, EYE - Refractive, EYE - Vitreo-Retinal
Case report A 40-year-old Asian man presented to the Emergency Department with a one day history of sudden onset visual disturbance in his right eye. He complained of image distortion and noted that objects now appeared smaller. He also described...
3D printing and ophthalmology
3 August 2023
| David Haider
|
EYE - General
3D printers have been available in the home market for many years, with the range of models increasing over time and the costs reducing. Historically, 3D printers have built a reputation of being complex and uncommon, most needing significant assembly...
Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals
1 February 2018
| Rod McNeil
|
EYE - Glaucoma
Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...
Cutting-edge practice in glaucoma care: what, how and why?
1 April 2016
| Nick Strouthidis, Winifred Nolan, Keith Barton
|
EYE - Glaucoma
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...
